Whatu0027s New In Alzheimeru0027s Medications?
Key takeaways
-
New disease-modifying medications like donanemab (Kisunla) and lecanemab (Leqembi) work by clearing beta-amyloid plaques in the brain and can slow cognitive decline.
-
Auvelity is the first non-antipsychotic medication approved specifically to treat agitation associated with Alzheimer’s disease, offering a safer alternative to traditional antipsychotics.
The landscape of Alzheimer’s disease treatments has shifted dramatically. For nearly two decades, medications only managed symptoms, such as memory loss or confusion, without attacking the root cause of the disease.
Today, the focus has shifted to disease-modifying therapies that slow disease progression, along with new options for managing behavioral symptoms.